`Pirozzolo Declaration
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`CELLTRION, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________________________________________
`
`Case IPR2017-01373
`U.S. Patent 6,407,213
`____________________________________________
`
`DECLARATION OF LISA J. PIROZZOLO IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`
`
`
`
`
`
`
`
`
`
`Genentech 2034
`Celltrion v. Genentech
`IPR2017-01373
`
`
`
`
`
`I, Lisa J. Pirozzolo, declare as follows:
`
`
`
`Case No. IPR2017-01373
`Pirozzolo Declaration
`
`1.
`
`I am an attorney licensed to practice law in the Commonwealth of
`
`Massachusetts.
`
`2.
`
`I am a partner at the law firm Wilmer Cutler Pickering Hale and Dorr
`
`LLP and have been litigating cases relating to patents for over twenty years.
`
`3.
`
`I am member in good standing of the Bar of the Commonwealth of
`
`Massachusetts, and am admitted to practice before the United States Courts of
`
`Appeals for the First and Federal Circuits, and the United States District Court for
`
`the District of Massachusetts.
`
`4. My Massachusetts Bar membership No. is 561922.
`
`5.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`6.
`
`I have never had an application denied for admission to practice
`
`before any court or administrative body.
`
`7.
`
`I have not had any sanctions or contempt citations imposed against me
`
`by any court or administrative body.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`9.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`
`
`
`1
`
`
`
`
`
`
`forth in 37 C.F.R. §§ 11.101 et seq., and disciplinary jurisdiction under 37 C.F.R.
`
`Case No. IPR2017-01373
`Pirozzolo Declaration
`
`§ 11.19(a).
`
`10. Currently, I am appearing pro hac vice in IPR2017-00731, IPR2017-
`
`00737, IPR2017-00804, IPR2017-00805, IPR2017-01121, IPR2017-01122,
`
`IPR2017-01139, IPR2017-01140, IPR2017-01488, IPR2017-01489. In the past
`
`three years, I have previously appeared pro hac vice before the Office in
`
`Fresenius-Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00223; and Fresenius-
`
`Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00227.
`
`11. Over the course of my career, I have been counsel in in various patent
`
`litigation matters before federal district courts and the Court of Appeals for the
`
`Federal Circuit. These cases have involved a variety of pharmaceutical products,
`
`including small molecules, biologics, and natural products.
`
`12.
`
`I am familiar with the subject matter of U.S. Patent No. 6,407,213,
`
`(“the ’213 patent”), the ’213 patent’s file history, the prior art presented in the
`
`petition, and the legal and factual issues raised by Petitioner in this proceeding. As
`
`a result, I have acquired substantial understanding of the underlying legal and
`
`technological issues at stake in this proceeding.
`
`I hereby declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements are made with the knowledge that willful false
`
`
`
`
`2
`
`
`
`
`
`
`statements and the like are punishable by fine, imprisonment, or both, under
`
`Case No. IPR2017-01373
`Pirozzolo Declaration
`
`Section 1001 of Title 18 of the United States Code.
`
`
`Respectfully submitted,
`
`
`
`/Lisa J. Pirozzolo/
`Lisa J. Pirozzolo
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`Lisa.Pirozzolo@wilmerhale.com
`Tel.: 617-526-6388
`Fax: 617-526-5000
`
`
`Dated: January 3, 2018
`
`
`
`
`
`3
`
`
`
`